53
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Cell-penetrating Peptides are Widely Used Molecular Transporter for Peptide Delivery in Cancer: Recent Advancements

ORCID Icon
Pages 401-405 | Received 04 Jul 2023, Accepted 13 Jul 2023, Published online: 03 Aug 2023

References

  • Fatima M , AbourehabMA, AggarwalGet al. Advancement of cell-penetrating peptides in combating triple-negative breast cancer. Drug Discov. Today121, 03353 (2022).
  • De Martini LB , SulmonaC, BrambillaLet al. Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs. Cells12(12), 1643 (2023).
  • Lundberg P , LangelÜ. A brief introduction to cell‐penetrating peptides. J. Mol. Recognit.16(5), 227–233 (2003).
  • Koren E , TorchilinVP. Cell-penetrating peptides: breaking through to the other side. Trends Mol. Med.18(7), 385–393 (2012).
  • Kurrikoff K , GestinM, LangelÜ. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery. Expert. Opin. Drug. Dev.13(3), 373–387 (2016).
  • Mäe M , MyrbergH, El-AndaloussiSet al. Design of a tumor homing cell-penetrating peptide for drug delivery. Int. J. Pept. Res. Ther.15, 11–15 (2009).
  • Park SE , SajidMI, ParangKet al. Cyclic cell-penetrating peptides as efficient intracellular drug delivery tools. Mol Pharm.16(9), 3727–3743 (2019).
  • Kardani K , MilaniA, HShabani S, BolhassaniA. Cell penetrating peptides: the potent multi-cargo intracellular carriers. Expert. Opin. Drug. Dev.16(11), 1227–1258 (2019).
  • Szabó I , YousefMA, SoltészDet al. Redesigning of cell-penetrating peptides to improve their efficacy as a drug delivery system. Pharmaceutics14(5), 907–919 (2022).
  • Wang X , ZhaoY, DongSet al. Cell-penetrating peptide and transferrin co-modified liposomes for targeted therapy of glioma. Molecules24(19), 3540 (2019).
  • Xu J , KhanAR, FuMet al. Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs. J. Control. Rel.309, 106–124 (2019).
  • Xie J , BiY, ZhangH, DongSet al. Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application. Front. Pharmacol.11, 697–716 (2020).
  • Schneider AF , KithilM, CardosoMCet al. Cellular uptake of large biomolecules enabled by cell-surface-reactive cell-penetrating peptide additives. Nat. Chem.13(6), 530–539 (2021).
  • Desale K , KucheK, JainS. Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics. Biomater. Sci.9(4), 1153–1188 (2021).
  • Teo SL , RennickJJ, YuenD, Al-WassitiHet al. Unravelling cytosolic delivery of cell penetrating peptides with a quantitative endosomal escape assay. Nat. Commun.12(1), 3721 (2021).
  • Kurrikoff K , VunkB, LangelÜ. Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics. Expert Opin. Biol. Ther.21(3), 361–370 (2021).
  • Morris MC , DepollierJ, MeryJet al. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol.19(2), 117–122 (2001).
  • Futaki S , SuzukiT, OhashiWet al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem.276(19), 5836–5840 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.